Related Experiment Video
Updated: Apr 12, 2026

A Standardized Procedure of Dressing Management for Toxic Epidermal Necrolysis
Published on: March 14, 2025
Alginate dressings for treating pressure ulcers
Jo C Dumville1, Samantha J Keogh, Zhenmi Liu
1School of Nursing, Midwifery and Social Work, University of Manchester, Manchester, UK, M13 9PL.
Limited evidence suggests alginate dressings show no significant difference in healing pressure ulcers compared to other treatments. More high-quality research is needed to clarify their effectiveness for pressure injury care.
Area of Science:
- Wound Care
- Dermatology
- Regenerative Medicine
Background:
- Pressure ulcers (bedsores) are localized skin and tissue injuries.
- Alginate dressings are a common treatment option for pressure ulcers.
- Evidence is needed to guide dressing selection for pressure ulcer treatment.
Purpose of the Study:
- To assess the effectiveness of alginate dressings in treating pressure ulcers across various care settings.
Main Methods:
- Searched multiple databases (Cochrane, MEDLINE, EMBASE, CINAHL) up to April 2015.
- Included randomized controlled trials (RCTs) comparing alginate dressings to alternative treatments or no dressing for stage II+ pressure ulcers.
- Two reviewers independently assessed studies, risk of bias, and extracted data.
Main Results:
- Six studies with 336 participants were included, each comparing alginate to a different intervention (e.g., hydrocolloid, silver alginate, radiant heat).
- All studies were small, had short follow-up periods, and were of low or very low quality.
- No significant difference was found between alginate dressings and alternative treatments regarding complete wound healing or adverse events.
Conclusions:
- The comparative effectiveness of alginate dressings for pressure ulcers remains unclear due to limited, low-quality evidence.
- Existing trials are small, short-term, and carry a risk of bias.
- Factors like cost and exudate management properties should be considered when choosing dressings for pressure ulcers.
More Related Videos
Related Concept Videos
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
However, this neutralization reaction between...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...

